Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts Sells 600 Shares

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 600 shares of the company’s stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $269.11, for a total transaction of $161,466.00. Following the completion of the sale, the executive vice president now directly owns 66,353 shares in the company, valued at approximately $17,856,255.83. The trade was a 0.90 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Johanna Roberts also recently made the following trade(s):

• On Monday, March 3rd, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $287.43, for a total transaction of $172,458.00.

Penumbra Stock Up 2.6 %

NYSE:PEN opened at $278.07 on Thursday. The stock has a 50-day simple moving average of $274.72 and a 200 day simple moving average of $244.49. Penumbra, Inc. has a 52-week low of $148.00 and a 52-week high of $310.00. The company has a market cap of $10.71 billion, a PE ratio of 817.85, a PEG ratio of 2.83 and a beta of 0.51. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 6.01.

Penumbra (NYSE:PEN) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.09. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. The company had revenue of $315.52 million during the quarter, compared to analysts’ expectations of $311.63 million. On average, sell-side analysts expect that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently weighed in on PEN shares. Truist Financial raised their price objective on shares of Penumbra from $285.00 to $325.00 and gave the stock a “buy” rating in a report on Wednesday, February 19th. Robert W. Baird lifted their price objective on Penumbra from $305.00 to $328.00 and gave the company an “outperform” rating in a research report on Wednesday, February 19th. Wells Fargo & Company boosted their price objective on Penumbra from $275.00 to $305.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 19th. Piper Sandler reaffirmed an “overweight” rating and issued a $330.00 price target (up from $250.00) on shares of Penumbra in a report on Wednesday, February 19th. Finally, Bank of America assumed coverage on shares of Penumbra in a research report on Friday, March 14th. They issued a “buy” rating and a $320.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Penumbra has an average rating of “Moderate Buy” and a consensus price target of $294.47.

Institutional Investors Weigh In On Penumbra

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Penumbra by 74.7% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,115 shares of the company’s stock valued at $740,000 after acquiring an additional 1,332 shares in the last quarter. Employees Retirement System of Texas boosted its position in Penumbra by 31.9% during the fourth quarter. Employees Retirement System of Texas now owns 5,273 shares of the company’s stock valued at $1,252,000 after purchasing an additional 1,274 shares during the last quarter. Jefferies Financial Group Inc. bought a new position in Penumbra in the fourth quarter valued at approximately $760,000. Polar Asset Management Partners Inc. increased its position in shares of Penumbra by 10.5% during the 4th quarter. Polar Asset Management Partners Inc. now owns 122,126 shares of the company’s stock worth $29,002,000 after purchasing an additional 11,605 shares during the last quarter. Finally, Cache Advisors LLC bought a new stake in shares of Penumbra during the 4th quarter worth approximately $534,000. 88.88% of the stock is currently owned by institutional investors and hedge funds.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.